Viridian Therapeutics, Inc.\DE (VRDN) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Viridian Therapeutics, Inc.\DE (VRDN) over the last 12 years, with Q3 2025 value amounting to -$2.6 million.
- Viridian Therapeutics, Inc.\DE's Other Gross PP&E Adjustments fell 41640.0% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 41640.0%. This contributed to the annual value of -$7.4 million for FY2024, which is 4693.45% up from last year.
- Latest data reveals that Viridian Therapeutics, Inc.\DE reported Other Gross PP&E Adjustments of -$2.6 million as of Q3 2025, which was down 41640.0% from -$2.0 million recorded in Q2 2025.
- In the past 5 years, Viridian Therapeutics, Inc.\DE's Other Gross PP&E Adjustments ranged from a high of $654000.0 in Q3 2021 and a low of -$14.0 million during Q4 2023
- Its 5-year average for Other Gross PP&E Adjustments is -$2.4 million, with a median of -$1.8 million in 2024.
- Per our database at Business Quant, Viridian Therapeutics, Inc.\DE's Other Gross PP&E Adjustments plummeted by 59297.12% in 2022 and then skyrocketed by 7304.58% in 2024.
- Over the past 5 years, Viridian Therapeutics, Inc.\DE's Other Gross PP&E Adjustments (Quarter) stood at -$2.7 million in 2021, then rose by 7.96% to -$2.4 million in 2022, then tumbled by 471.98% to -$14.0 million in 2023, then surged by 46.93% to -$7.4 million in 2024, then surged by 65.15% to -$2.6 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$2.6 million for Q3 2025, versus -$2.0 million for Q2 2025 and -$2.1 million for Q1 2025.